Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Quest (DGX) Q4 Earnings: What To Expect

Quest (DGX) Q4 Earnings: What To Expect

DGX : 191.25 (+0.28%)
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing

DGX : 191.25 (+0.28%)
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year

SECAUCUS, N.J. , Jan. 21, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune ®...

DGX : 191.25 (+0.28%)
3 Unpopular Stocks with Questionable Fundamentals

3 Unpopular Stocks with Questionable Fundamentals

DGX : 191.25 (+0.28%)
JACK : 21.36 (-6.19%)
CHCO : 127.72 (-0.09%)
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect

Jennifer Erickson succeeds   longtime CEO David Dexter following more than 26 years of service

DGX : 191.25 (+0.28%)
3 Mid-Cap Stocks We Find Risky

3 Mid-Cap Stocks We Find Risky

DGX : 191.25 (+0.28%)
BG : 118.65 (+2.41%)
BF.B : 29.48 (+0.10%)
3 Reasons to Sell DGX and 1 Stock to Buy Instead

3 Reasons to Sell DGX and 1 Stock to Buy Instead

DGX : 191.25 (+0.28%)
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025

DGX : 191.25 (+0.28%)
EXAS : 103.32 (+0.14%)
ILMN : 117.25 (-2.06%)
ARVN : 13.29 (-1.41%)
PFE : 27.05 (-0.62%)
QTRX : 6.17 (+1.31%)
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

SECAUCUS, N.J. , Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full...

DGX : 191.25 (+0.28%)
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium

SECAUCUS, N.J. , Jan. 6, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor...

DGX : 191.25 (+0.28%)

Barchart Exclusives

As Crypto Collapses, Buy This 1 Trillion-Dollar Dividend Stock Instead
As high-flying tech stocks and crypto stumble, this 1 trillion-dollar blue-chip dividend stock could be an ideal investment candidate now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar